scholarly article | Q13442814 |
P356 | DOI | 10.1007/PL00004956 |
P698 | PubMed publication ID | 9089668 |
P50 | author | Margarita Dubocovich | Q28163057 |
P2093 | author name string | Masana MI | |
Iacob S | |||
Sauri DM | |||
P433 | issue | 3 | |
P921 | main subject | melatonin | Q180912 |
P304 | page(s) | 365-375 | |
P577 | publication date | 1997-03-01 | |
P1433 | published in | Naunyn-Schmiedeberg's Archives of Pharmacology | Q1468251 |
P1476 | title | Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor | |
P478 | volume | 355 |
Q44622905 | A circadian clock in the fish retina regulates dopamine release via activation of melatonin receptors |
Q37225147 | A molecular and chemical perspective in defining melatonin receptor subtype selectivity |
Q34358552 | Abnormal response of the proliferation and differentiation of growth plate chondrocytes to melatonin in adolescent idiopathic scoliosis. |
Q31715327 | Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock |
Q74340318 | Acute low doses of melatonin restore full sexual activity in impotent male rats |
Q73264283 | Acute low doses of melatonin stimulate rat sex behavior: the role of serotonin neurotransmission |
Q89394268 | Aerobic exercise enhanced endothelium-dependent vasorelaxation in mesenteric arteries in spontaneously hypertensive rats: the role of melatonin |
Q51739582 | Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors. |
Q46853883 | An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT(2) melatonin receptor antagonist |
Q45394038 | Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus |
Q53307900 | Bioactivity-guided synthesis of gramine derivatives as new MT1 and 5-HT1A receptors agonists. |
Q40895000 | Characterisation of human melatonin mt(1) and MT(2) receptors by CRE-luciferase reporter assay |
Q92359520 | Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT1 and MT2 receptors |
Q82767935 | Characterization of two different melatonin binding sites in peripheral tissues of the teleost Tinca tinca |
Q43593899 | Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 . |
Q44485803 | Conformation by NMR of two tetralin-based receptor ligands |
Q39454848 | Description of the constitutive activity of cloned human melatonin receptors hMT(1) and hMT(2) and discovery of inverse agonists |
Q34171739 | Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands |
Q33986906 | Design and synthesis of melatonin receptors agonists and antagonists |
Q35548289 | Digging deep – structure–function relationships in the melatonin receptor family |
Q22251337 | Dopamine and retinal function |
Q42520978 | Dual coupling of MT(1) and MT(2) melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure. |
Q40551380 | Effect of melatonin on the oxidative stress in N1E-115 cells is not mediated by mt1 receptors |
Q39336193 | Evidence of the receptor-mediated influence of melatonin on pancreatic glucagon secretion via the Gαq protein-coupled and PI3K signaling pathways |
Q43181873 | Expression of melatonin (MT1, MT2) and melatonin-related receptors in the adult rat testes and during development. |
Q44032684 | First cloning and functional characterization of a melatonin receptor in fish brain: a novel one? |
Q36282807 | Functional MT1 and MT2 melatonin receptors in mammals |
Q93551696 | G Protein-Coupled Receptors |
Q21093414 | GPR50 is the mammalian ortholog of Mel1c: evidence of rapid evolution in mammals |
Q44489315 | Gene expression and functional characterization of melatonin receptors in the spinal cord of the rat: implications for pain modulation |
Q36598788 | Genetic deletion of MT(1) and MT(2) melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/HeN mice |
Q36423565 | Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice |
Q44090372 | Identification of cysteines involved in ligand binding to the human melatonin MT(2) receptor |
Q28345752 | Identification of the dopamine autoreceptor in the guinea-pig retina as D(2) receptor using novel subtype-selective antagonists |
Q24623433 | International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors |
Q24672082 | Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists |
Q28570757 | Localization and regulation of dopamine receptor D4 expression in the adult and developing rat retina |
Q30441789 | Localization of a circadian clock in mammalian photoreceptors |
Q28207731 | MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells |
Q28083929 | MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective |
Q44074088 | MT1 melatonin receptor mRNA expression exhibits a circadian variation in the rat suprachiasmatic nuclei |
Q42716227 | MT1-selective melatonin receptor ligands: synthesis, pharmacological evaluation, and molecular dynamics investigation of N-{[(3-O-substituted)anilino]alkyl}amides. |
Q34458636 | MT2 Receptors Mediate the Inhibitory Effects of Melatonin on Nitric Oxide-Induced Relaxation of Porcine Isolated Coronary Arteries |
Q34440574 | Melatonergic drugs in development |
Q82240414 | Melatonin |
Q93498531 | Melatonin |
Q43800993 | Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. |
Q37031595 | Melatonin and the hair follicle |
Q44027007 | Melatonin as an effective protector against doxorubicin-induced cardiotoxicity |
Q37808501 | Melatonin as the most effective organizer of the rhythm of protein synthesis in hepatocytes in vitro and in vivo |
Q35626942 | Melatonin attenuates memory impairment induced by Klotho gene deficiency via interactive signaling between MT2 receptor, ERK, and Nrf2-related antioxidant potential |
Q40660868 | Melatonin biological activity and binding sites in human melanoma cells |
Q51367039 | Melatonin improves reprogramming efficiency and proliferation of bovine-induced pluripotent stem cells. |
Q48720706 | Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin receptor |
Q36494644 | Melatonin inhibits nitric oxide signaling by increasing PDE5 phosphorylation in coronary arteries |
Q43709366 | Melatonin mediates two distinct responses in vascular smooth muscle |
Q38863152 | Melatonin membrane receptor type MT1 modulates cell-mediated immunity in the seasonally breeding tropical rodent Funambulus pennanti. |
Q37007133 | Melatonin receptor genes in vertebrates |
Q41746734 | Melatonin receptor genes. |
Q34430967 | Melatonin receptor signaling: finding the path through the dark |
Q54335751 | Melatonin receptor-mediated protection against myocardial ischemia/reperfusion injury: role of SIRT1. |
Q33834137 | Melatonin receptors and ligands |
Q34182743 | Melatonin receptors and their regulation: biochemical and structural mechanisms |
Q46821222 | Melatonin receptors in brain areas and ocular tissues of the teleost Tinca tinca: characterization and effect of temperature |
Q43986225 | Melatonin receptors in rat hippocampus: molecular and functional investigations |
Q36790172 | Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? |
Q43849061 | Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge |
Q43892673 | Modulation of dopamine release in the guinea-pig retina by G(i)- but not by G(s)- or G(q)-protein-coupled receptors |
Q35029011 | Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats |
Q38046127 | Molecular mechanisms of melatonin's inhibitory actions on breast cancers. |
Q44491221 | Mutagenesis studies of the human MT2 melatonin receptor |
Q43281456 | N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands |
Q40807594 | N1E-115 mouse neuroblastoma cells express MT1 melatonin receptors and produce neurites in response to melatonin |
Q37783712 | Neuroprotection in glaucoma – Is there a future role? |
Q40645395 | New selective ligands of human cloned melatonin MT1 and MT2 receptors. |
Q33879842 | Novel non-indolic melatonin receptor agonists differentially entrain endogenous melatonin rhythm and increase its amplitude |
Q39037378 | Nycthemeral variation in melatonin receptor expression in the lymphoid organs of a tropical seasonal breeder Funambulus pennanti. |
Q34478494 | Pharmacological characterisation of melatonin mt1 receptor-mediated stimulation of [35S]-GTPgammaS binding |
Q24675167 | Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors |
Q39344288 | Phosphorylation of cyclic AMP-response element-binding protein (CREB) is influenced by melatonin treatment in pancreatic rat insulinoma β-cells (INS-1). |
Q35880158 | Physiological and metabolic functions of melatonin |
Q44392713 | Protective effect of melatonin on myocardial infarction |
Q37763715 | Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists. |
Q44034639 | Receptor-mediated modulation of avian caecal muscle contraction by melatonin: role of tyrosine protein kinase |
Q102319570 | Retinal and Extra-Retinal Photoreceptor responses and reproductive performance of Japanese quail (Coturnix coturnix japonica) following exposure to different photoperiodic regime |
Q38226491 | Role of the dopaminergic system in the development of myopia in children and adolescents |
Q48584554 | Sleep-inducing effects of exogenous melatonin administration |
Q44157942 | Small doses of melatonin increase intestinal motility in rats |
Q46427683 | Stimulation of melatonin receptors decreases calcium levels in xenopus tectal cells by activating GABA(C) receptors |
Q43179062 | Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats. |
Q28139033 | Substrate specificity and inhibition studies of human serotonin N-acetyltransferase |
Q46624978 | Sustained anti-beta-adrenergic effect of melatonin in guinea pig heart papillary muscle |
Q53204974 | Synthesis and configuration determination of all enantiopure stereoisomers of the melatonin receptor ligand 4-phenyl-2-propionamidotetralin using an expedient optical resolution of 4-phenyl-2-tetralone. |
Q28542535 | Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands |
Q42824016 | Synthesis, enantiomeric resolution, and structure-activity relationship study of a series of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene MT2 receptor antagonists |
Q42828970 | Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands. |
Q34463520 | Targeted disruption of the mouse Mel(1b) melatonin receptor |
Q30486707 | The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors |
Q35167615 | The MT2 receptor stimulates axonogenesis and enhances synaptic transmission by activating Akt signaling |
Q38757896 | The P2Y1 receptor-mediated leukocyte adhesion to endothelial cells is inhibited by melatonin |
Q37184249 | The circadian clock system in the mammalian retina. |
Q48248895 | The effect of myocardial infarction on the synthesis, concentration and receptor expression of endogenous melatonin |
Q43231267 | The influence of melatonin on hair physiology |
Q24293767 | The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization |
Q28343267 | The putative melatonin receptor antagonist GR128107 is a partial agonist on Xenopus laevis melanophores |
Q34118849 | Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease |
Q37404821 | Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology |
Q38868297 | Update on melatonin receptors: IUPHAR Review 20. |
Search more.